State Medicaid DUR Board Meeting - Revision 2
This is a Notice Revision
You are currently viewing a revision of a notice. This is a previous copy of a notice that has been published more recently. To view the current version of this notice, click here.
Please Note: Only the files that were associated to this version are included in the Download Attachments section. If that section does not display, all attachments were removed from this version of the notice.
General Information
- Government Type
- State Agency
- Entity
- Department of Health and Human Services (DHHS)
- Public Body
- Drug Utilization Review Board
Notice Information
- Notice Title
- State Medicaid DUR Board Meeting
- Notice Type(s)
- Meeting
- Event Start Date & Time
- January 8, 2026 07:15 AM
- Event End Date & Time
- January 8, 2026 08:30 AM
- Event Deadline Date & Time
- 01/08/26 08:30 AM
- Description/Agenda
- Drug Utilization Review Board Meeting Agenda Thursday, January 8, 2026 7:15 a.m. to 8:30 a.m. Google Meet joining info Video call link: meet.google.com/zue-rrqz-rpb Or dial: (US) +1 904-900-0180 PIN: 172 873 306# Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order - Sharon Weinstein, MD a) Welcome and Introductions b) Review and Approval of Minutes c) Housekeeping - Luis Moreno, PharmD 2) Prior Authorization Updates - Luis Moreno, PharmD 3) Review Topic a) Combination Treatment with Botox and a CGRP Antagonist in the Setting of Chronic Migraine - Monet Luloh, PharmD i) Committee Discussion/Questions ii) Committee Action 4) Public Comment a) Axsome Therapeutics: Symbravo (meloxicam/rizatriptan) - Kyle Knudsen, PharmD 5) Review New Prior Authorization Criteria a) Auvelity (dextromethorphan and bupropion), Fetzima (levomilnacipran), Trintellix (vortioxetine), Viibryd (vilazodone) - Skylar Fenton, PharmD i) Committee Discussion/Questions ii) Committee Action b) Qelbree (viloxazine) - Kyu Yun Park, PharmD i) Committee Discussion/Questions ii) Committee Action
- Notice of Special Accommodations (ADA)
- In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
- Notice of Electronic or Telephone Participation
- N/A
Meeting Information
- Meeting Location
-
Video/Teleconferencing
Video/Teleconferencing, UT 84116
Show in Apple Maps Show in Google Maps - Contact Name
- Luis Moreno
- Contact Email
- lmoreno@utah.gov
- Contact Phone
- 801-538-6155
Notice Posting Details
- Notice Posted On
- December 23, 2025 08:13 PM
- Notice Last Edited On
- December 23, 2025 08:24 PM
- Deadline Date
- January 8, 2026 08:30 AM